Compare · CHPT vs ZBH
CHPT vs ZBH
Side-by-side comparison of ChargePoint Holdings Inc. (CHPT) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- CHPT operates in Consumer Discretionary, while ZBH operates in Health Care - the two are in different parts of the market.
- ZBH is the larger of the two at $19.12B, about 126.4x CHPT ($151.2M).
- ZBH has been more active in the news (7 items in the past 4 weeks vs 3 for CHPT).
- Both have 25 recent analyst ratings on file.
- Company
- ChargePoint Holdings Inc.
- Zimmer Biomet Holdings Inc.
- Price
- -
- -
- Market cap
- $151.2M
- $19.12B
- 1M return
- +7.76%
- -
- 1Y return
- -49.57%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 3
- 7
- Recent ratings
- 25
- 25
ChargePoint Holdings Inc.
ChargePoint Holdings, Inc. provides electric vehicle (EV) charging networks and charging solutions in the United States. It offers a portfolio of hardware, software, and services for commercial, fleet, and residential customers. The company was founded in 2007 and is headquartered in Campbell, California.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest CHPT
- ChargePoint to Announce Second Quarter Fiscal Year 2027 Financial Results on September 2, 2026
- ChargePoint and Portland International Airport Set New Standard for Rental Car Electrification with Industry-Leading Overhead Fast Charging
- ChargePoint and Mercedes-Benz Partner to Simplify Fleet Electrification with End-to-End Charging Solutions
- ChargePoint Holdings Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure
- Director Singh-Bushell Ekta was granted 25,050 shares, increasing direct ownership by 122% to 45,627 units (SEC Form 4)
- Director Heystee Susan was granted 25,050 shares, increasing direct ownership by 120% to 45,945 units (SEC Form 4)
- Director Linse Michael was granted 27,555 shares, increasing direct ownership by 129% to 48,930 units (SEC Form 4)
- Director Leschly Mark was granted 26,386 shares, increasing direct ownership by 123% to 47,761 units (SEC Form 4)
- Director Harris Jeffrey was granted 28,390 shares, increasing direct ownership by 133% to 49,765 units (SEC Form 4)
- Director Harries Axel was granted 25,050 shares, increasing direct ownership by 117% to 46,425 units (SEC Form 4)
Latest ZBH
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Grp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)
- UBS initiated coverage on Zimmer Biomet with a new price target
- SEC Form 3 filed by new insider Desai Chintan
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region